Scinai Immunotherapeutics Ltd. Annual Net Cash Provided by (Used in) Operating Activities in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Scinai Immunotherapeutics Ltd. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2021 to 2023.
  • Scinai Immunotherapeutics Ltd. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$3.06M, a 177% decline year-over-year.
  • Scinai Immunotherapeutics Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$9.38M, a 29.1% decline from 2022.
  • Scinai Immunotherapeutics Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$7.27M, a 2.17% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$9.38M -$2.12M -29.1% Jan 1, 2023 Dec 31, 2023 20-F 2024-05-15
2022 -$7.27M +$161K +2.17% Jan 1, 2022 Dec 31, 2022 20-F 2024-05-15
2021 -$7.43M Jan 1, 2021 Dec 31, 2021 20-F 2024-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.